In 2021, a meta-analysis of nine studies conducted from 2012 to 2018, including 772 GDM patients and 857 controls, concluded that circulating chemerin levels in women with GDM did not differ significantly from those of controls with normal glucose tolerance [55]. This evidence concerns the gene RARRES2 and gestational diabetes.